VERO BEACH, Fla., April 4, 2025 /PRNewswire/ — Frederick “Derick” Cooper, CEO of QOL Medical, continues to make a lasting impact across multiple communities through a series of charitable donations aimed at supporting religious organizations and their missions. Over the past two years,…

Two presentations in the General Neurology and Late Breaker sessions will respectively cover new clinical and microRNA data from NeuroSense CAMBRIDGE, Mass., April 4, 2025 /PRNewswire/ — NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN), a leading clinical-stage biotechnology company focused…

PARAMUS, N.J., April 4, 2025 /PRNewswire/ — SK Life Science, Inc., a global leader in developing treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present meaningful encore data on XCOPRI® (cenobamate tablets) CV, an…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.